RHYTHM Biosciences Ltd (RHY) — Financial Flexibility Index
RHYTHM Biosciences Ltd (RHY) has a Financial Flexibility Index of -2.33x as of December 2025. Free cash flow of AU$-2.22 Million (operating CF AU$-2.22 Million minus capex AU$1.02K) represents -2% of total liabilities (AU$955.41K). Also explore RHY shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
RHYTHM Biosciences Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for RHYTHM Biosciences Ltd across 9 annual periods. Check RHY capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for RHYTHM Biosciences Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for RHYTHM Biosciences Ltd. For the full company profile including market capitalisation, see market value of RHYTHM Biosciences Ltd.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.33x | AU$-2.90 Million | AU$-2.92 Million | AU$2.17 Million | ▲ +85.6% |
| 2024 | -9.29x | AU$-6.05 Million | AU$-6.14 Million | AU$651.54K | ▼ -146.7% |
| 2023 | -3.77x | AU$-6.86 Million | AU$-6.96 Million | AU$1.82 Million | ▲ +35.1% |
| 2022 | -5.81x | AU$-6.19 Million | AU$-6.21 Million | AU$1.07 Million | ▼ -48.4% |
| 2021 | -3.91x | AU$-5.33 Million | AU$-5.40 Million | AU$1.36 Million | ▼ -16.5% |
| 2020 | -3.36x | AU$-2.70 Million | AU$-2.74 Million | AU$802.85K | ▲ +54.9% |
| 2019 | -7.46x | AU$-2.83 Million | AU$-2.94 Million | AU$379.71K | ▲ +18.0% |
| 2018 | -9.10x | AU$-1.34 Million | AU$-1.65 Million | AU$147.38K | ▼ -10804.0% |
| 2017 | 0.08x | AU$10.75K | AU$-13.00 | AU$126.48K | — |